Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02228135 · ClinicalTrials.gov registry record

The Effect of Dexamethasone Dosing on Post-tonsillectomy Hemorrhage

A clinical trial of Tonsillectomy and Adenotonsillectomy, sponsored by Nicole Elsey.

Completed
Registry status
9,843
Enrollment target
1
Study location

NCT02228135 is a study of Tonsillectomy and Adenotonsillectomy that has completed, run by Nicole Elsey. The registered enrollment target is 9,843 participants, above the 152-participant average among 6 other Tonsillectomy trials with a reported enrollment target (6376% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02228135, a study of Tonsillectomy and Adenotonsillectomy, has completed, sponsored by Nicole Elsey.

COMPLETED
Registry status
9,843 participants
Enrollment target
1
Study location

Study Summary

This is a retrospective chart review looking at the effect of dexamethasone dosing on post-tonsillectomy hemorrhage.

Interventions

  • DRUG Dexamethasone

Study Locations (1)

Ohio

  • Nationwide Children's Hospital - Columbus

Trial Details

FieldValue
Enrollment Target 9,843 participants
Start Date 2014-09
Est. Completion 2017-02

Sponsor

Nicole Elsey

1 total trials

What the Registry Record Tells You About NCT02228135

The ClinicalTrials.gov registry entry for NCT02228135 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 9,843 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 152-participant average among 6 other Tonsillectomy trials with a reported enrollment target (6376% higher). The listed sponsor is Nicole Elsey, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Tonsillectomy appearing as the primary indexed condition, and to 1 intervention - of which Dexamethasone is the first listed.

NCT02228135 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT02228135 about?

NCT02228135 is a clinical study titled "The Effect of Dexamethasone Dosing on Post-tonsillectomy Hemorrhage". This is a retrospective chart review looking at the effect of dexamethasone dosing on post-tonsillectomy hemorrhage.

What is the current status of trial NCT02228135?

This trial is currently completed. The enrollment target is 9,843 participants. The study started on 2014-09. Estimated completion is 2017-02.

What conditions does trial NCT02228135 study?

This clinical trial studies the following conditions: Tonsillectomy, Adenotonsillectomy.

What interventions are being tested in trial NCT02228135?

The interventions under investigation include: Dexamethasone (DRUG).

Who is sponsoring clinical trial NCT02228135?

This trial is sponsored by Nicole Elsey, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02228135 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Tonsillectomy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.